NCT00802139

Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin

A Prospective, Randomized, Multi-centered Trial to Compare the Efficacy and Safety of Intravenous Iron Sucrose (Venoferrum®) With Oral Iron Acetyl-transferrin Hydroglycerin (Bolgre®) in Pregnant Women With Iron Deficiency Anemia

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 58 (actual)
• Sponsor: JW Pharmaceutical · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

multi-center, prospective, randomized, open-labeled, active-drug-controlled, two-parallel-group-comparison(venoferrun group vs Bolgre group)study

Conditions

• Iron Deficiency Anemia

Interventions

Type	Name	Description
DRUG	venoferrum(iron sucrose)	administer once weekly calculated quantity of Venoferrum® ampoules according to body weight and Hb level.
DRUG	Bolgre (Iron acetyl-transferase)	Twice daily administration with Bolgre® soln (one pouch per dosing which is equivalent to 40mg of iron) for 5 weeks

Timeline

• Start date: 2008-02-01
• Primary completion: 2009-06-01
• Completion: 2010-10-01
• First posted: 2008-12-04
• Last updated: 2012-03-30

Locations

3 sites across 1 country: South Korea